Method for preparing dipeptidyl peptidase-IV inhibitor

A compound, the technology of camphorsulfonic acid, applied in the field of compound preparation, can solve the problems of high product cost and expensive reagents

Inactive Publication Date: 2010-12-29
BEIJING HOPE PHARMA
View PDF3 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Both of the above-mentioned methods have the problems that t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing dipeptidyl peptidase-IV inhibitor
  • Method for preparing dipeptidyl peptidase-IV inhibitor
  • Method for preparing dipeptidyl peptidase-IV inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1: 7-[3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-trifluoromethane Preparation of base-1,2,4-triazolo[4,3-a]pyrazine (III)

[0029] Add 10g of compound (II) and 110ml of methanol into the reaction kettle, heat up to about 40°C and stir to dissolve, add 2g of palladium carbon, pressurize and roughly estimate the hydrogen absorption according to the theoretical amount, about 6-8 hours, after the reaction is completed, filter out the palladium Carbon, 200ml isopropanol was added to the filtrate, stirred for 1 hour, and compound III was obtained by filtration.

Embodiment 2

[0030] Example 2: 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 -Preparation of trifluoromethyl-1,2,4-triazolo[4,3-a]pyrazine camphorsulfonate

[0031] Dissolve 10 g of compound III in 100 ml of toluene, add 6.2 g of D-camphorsulfonic acid monohydrate, heat and stir overnight. Cool, filter, and recrystallize the solid from toluene. Camphorsulfonate is obtained.

Embodiment 3

[0032] Example 3: 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 - Preparation of trifluoromethyl-1,2,4-triazolo[4,3-a]pyrazine tartrate

[0033] Dissolve 10 g of compound III in 100 ml of toluene, add 3.7 g of (-)-tartaric acid, and react at room temperature for 48 hours. A white solid precipitated out of the system, was filtered, and the solid was recrystallized from toluene. Get tartrate.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a method for preparing a dipeptidyl peptidase-IV inhibitor, and in particular relates to a method for preparing 7-[3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-trifluoromethyl-1,2,4-triazol[4,3-a]pyrazine raceme or an optically pure (R) or (S) compound thereof. The method comprises the following steps of: (1) performing hydrogenation reduction to obtain racemate; (2) reacting the racemate with camphorsulfonic acid or tartaric acid; and (3) converting a salt obtained in the step 2 into a corresponding alkali. The method has low cost and can be applied to industrial production.

Description

Field of invention: [0001] The present invention relates to a preparation method of a compound, especially optically pure 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5 , The preparation method of 6,7,8-tetrahydro-3-trifluoromethyl-1,2,4-triazolo[4,3-a]pyrazine. Background technique: [0002] 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-trifluoromethane Base-1,2,4-triazolo[4,3-a]pyrazine, or sitagliptin, is a potent inhibitor of dipeptidyl peptidase-IV for the treatment and prophylaxis of Diseases and conditions with base peptidase-IV inhibitors. [0003] There are several disclosed preparation methods of sitagliptin. WO2004085661 and WO20040876 describe the use of (s)-phenylglycineamide to obtain chiral compounds and further prepare sitagliptin; WO2005030127 and WO2006081151 describe the use of Asymmetric hydrogenation of transition metal precursors complexed with ferrocenyl diphosphine ligands. Both of the above-mentioned methods ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D487/04C07B57/00A61K31/4985A61P43/00
Inventor 王海军张勇刘长茹艾海马刘艳玲裴九宏
Owner BEIJING HOPE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products